Gerlach M - Search Results

1

Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.

Klampfl K, Taurines R, Preuss A, Burger R, Rothenhöfer S, Wewetzer Ch, Pfuhlmann B, Fegert J, Gerlach M, Mehler-Wex C. Klampfl K, et al. Among authors: gerlach m. Pharmacopsychiatry. 2010 Mar;43(2):58-65. doi: 10.1055/s-0029-1239540. Epub 2009 Dec 10. Pharmacopsychiatry. 2010. PMID: 20336598

2

The relation between dosage, serum concentrations, and clinical outcome in children and adolescents treated with sertraline: a naturalistic study.

Taurines R, Burger R, Wewetzer C, Pfuhlmann B, Mehler-Wex C, Gerlach M, Egberts K. Taurines R, et al. Among authors: gerlach m. Ther Drug Monit. 2013 Feb;35(1):84-91. doi: 10.1097/FTD.0b013e31827a1aad. Ther Drug Monit. 2013. PMID: 23318280

3

Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood Disorders.

Albantakis L, Egberts K, Burger R, Kulpok C, Mehler-Wex C, Taurines R, Unterecker S, Wewetzer C, Romanos M, Gerlach M. Albantakis L, et al. Among authors: gerlach m. Pharmacopsychiatry. 2017 Nov;50(6):248-255. doi: 10.1055/s-0043-109695. Epub 2017 May 23. Pharmacopsychiatry. 2017. PMID: 28561203

4

Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.

Gerlach M, Hünnerkopf R, Rothenhöfer S, Libal G, Burger R, Clement HW, Fegert JM, Wewetzer Ch, Mehler-Wex C. Gerlach M, et al. Pharmacopsychiatry. 2007 Mar;40(2):72-6. doi: 10.1055/s-2007-972573. Pharmacopsychiatry. 2007. PMID: 17447177 Clinical Trial.

5

Therapeutic drug monitoring in child and adolescent psychiatry.

Egberts KM, Mehler-Wex C, Gerlach M. Egberts KM, et al. Among authors: gerlach m. Pharmacopsychiatry. 2011 Sep;44(6):249-53. doi: 10.1055/s-0031-1286291. Epub 2011 Sep 28. Pharmacopsychiatry. 2011. PMID: 21959786 Review.

6

Therapeutic drug monitoring of children and adolescents treated with fluoxetine.

Koelch M, Pfalzer AK, Kliegl K, Rothenhöfer S, Ludolph AG, Fegert JM, Burger R, Mehler-Wex C, Stingl J, Taurines R, Egberts K, Gerlach M. Koelch M, et al. Among authors: gerlach m. Pharmacopsychiatry. 2012 Mar;45(2):72-6. doi: 10.1055/s-0031-1291294. Epub 2011 Nov 15. Pharmacopsychiatry. 2012. PMID: 22086744 Clinical Trial.

7

Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone.

Taurines R, Fekete S, Preuss-Wiedenhoff A, Warnke A, Wewetzer C, Plener P, Burger R, Gerlach M, Romanos M, Egberts KM. Taurines R, et al. Among authors: gerlach m. J Neural Transm (Vienna). 2022 Jun;129(5-6):689-701. doi: 10.1007/s00702-022-02485-6. Epub 2022 Mar 18. J Neural Transm (Vienna). 2022. PMID: 35303169 Free PMC article.

8

Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia.

Taurines R, Thome J, Duvigneau JC, Forbes-Robertson S, Yang L, Klampfl K, Romanos J, Müller S, Gerlach M, Mehler-Wex C. Taurines R, et al. Among authors: gerlach m. Eur Child Adolesc Psychiatry. 2010 May;19(5):441-8. doi: 10.1007/s00787-009-0074-z. Epub 2009 Nov 6. Eur Child Adolesc Psychiatry. 2010. PMID: 19894076

9

Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice.

Wohkittel C, Gerlach M, Taurines R, Wewetzer C, Unterecker S, Burger R, Schreck D, Mehler-Wex C, Romanos M, Egberts K. Wohkittel C, et al. Among authors: gerlach m. J Neural Transm (Vienna). 2016 Aug;123(8):1021-31. doi: 10.1007/s00702-016-1573-y. Epub 2016 May 24. J Neural Transm (Vienna). 2016. PMID: 27221285

10

Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical Practice.

Fekete S, Wewetzer C, Mehler-Wex C, Holtkamp K, Burger R, Reichert S, Taurines R, Romanos M, Gerlach M, Egberts K. Fekete S, et al. Among authors: gerlach m. Ther Drug Monit. 2017 Jun;39(3):273-281. doi: 10.1097/FTD.0000000000000398. Ther Drug Monit. 2017. PMID: 28383317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

472 results

Search Page